Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 100

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 100
---
 for a virtual meeting.

<div align='center'>61</div>

Stock Plan

In March 2021, we adopted the Global Share Incentive Plan (2021) (the “2021 Plan”), providing for the grant of non-qualified stock options and incentive stock options to purchase shares of our common stock, restricted and unrestricted share awards and grant of restricted stock units, to the employees, services providers, directors, officers, consultants and affiliates of the Company and its subsidiaries. The Plan, including the Appendix for Israeli taxpayers was approved by our stockholders by written consent on March 10, 2021. We initially reserved 5,000,000 shares of our Common Stock issuable under the 2021 Plan.

On November 11, 2024, following discussions with the management of the Company, the Board has determined that it is advisable and in the best interests of the Company and its stockholders to further amend the Plan, as amended (“Amendment #2”), to reduce the maximum number of shares reserved for issuance under the Plan from 20,000,000 shares of Common Stock to 10,000,000 shares of Common Stock. Amendment No. 2 became effective on the date of the approval by the Board of Directors, but it is subject to approval by the Company’s shareholders within 12 months, pursuant to section 422(b)(1) of the Internal Revenue Code.

Outstanding Equity Awards at Fiscal Year End

The following table sets forth certain information as of December 31, 2024 about our 2021 Plan under which our equity securities are authorized for issuance.

| Plan Category                                                  |     | (a)                             
 Number of Securities            
 to be                           
 Issued Upon                     
 Exercise of Outstanding Options |           |     | (b)                          
 Weighted-                    
 Average                      
 Exercise                     
 Price of Outstanding Options |      |     | (c)                                                          
 Number of Securities Remaining Available for Future Issuance 
 Under Equity Compensation Plans (Excluding                   
 Securities                                                   
 Reflected                                                    
 In Column (a))                                               |        |
|:---------------------------------------------------------------|:----|:--------------------------------|----------:|:----|:-----------------------------|-----:|:----|:-------------------------------------------------------------|-------:|
| Equity compensation plans approved by security holders         |     |                                 | 2,200,000 |     | $                            | 0.31 |     |                                                              |    --- |
| Equity compensation plans not approved by security holders (1) |     |                                 | 2,760